HomeTrialNCT04534127
🔬NCT04534127NARECRUITING

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Study Summary

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia

View on ClinicalTrials.gov ↗
Study Details
Enrollment56 participants
Primary Completion
Lead SponsorAlpha Tau Medical LTD.
Data Retrieved2026-06-17 02:56:49.846063+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.